Su C - Search Results

1

[Combination of bortezomib and dexamethasone for newly diagnosed multiple myeloma].

Li J, Zeng LJ, Zhao Y, Su C, Huang BH. Li J, et al. Among authors: su c. Zhonghua Xue Ye Xue Za Zhi. 2009 Aug;30(8):543-7. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19954643 Chinese.

2

[Efficacy of bortezomib combined dexamethasone in 24 patients with multiple myeloma].

Li J, Zhao Y, Luo SK, Huang BH, Ding Y, Tong XZ, Wang HH, Zheng D, Su C, Peng AH. Li J, et al. Among authors: su c. Ai Zheng. 2008 Apr;27(4):429-34. Ai Zheng. 2008. PMID: 18423132 Free article. Chinese.

3

[The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma].

Li J, Zhao Y, Luo SK, Huang BH, Zhang GC, Peng AH, Zheng D, Su C, Xu DR, Tong XZ, Gu JL, Ding Y. Li J, et al. Among authors: su c. Zhonghua Yi Xue Za Zhi. 2008 Aug 5;88(30):2140-3. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080477 Chinese.

4

[The effects and safety of bortezomib combined with dexamethasone in the treatment of primary systemic amyloidosis].

Li J, Zhao Y, Zeng LJ, Su C, Wang HH. Li J, et al. Among authors: su c. Zhonghua Nei Ke Za Zhi. 2009 Sep;48(9):741-4. Zhonghua Nei Ke Za Zhi. 2009. PMID: 20079210 Chinese.

5

[Correlation of CD19 positive cell counts in bone marrow with therapeutic efficacy in patients with multiple myeloma].

Zhang L, Zhou ZH, Li XY, Ouyang J, Su C, Li J, Luo SK. Zhang L, et al. Among authors: su c. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):64-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21362223 Chinese.

6

Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma.

Gu JL, Li J, Zhou ZH, Liu JR, Huang BH, Zheng D, Su C. Gu JL, et al. Among authors: su c. Biochem Biophys Res Commun. 2012 Apr 13;420(3):644-50. doi: 10.1016/j.bbrc.2012.03.056. Epub 2012 Mar 17. Biochem Biophys Res Commun. 2012. PMID: 22450313

7

Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma.

Zheng D, Li J, Huang BH, Liu JR, Zou WY, Su C. Zheng D, et al. Among authors: su c. Chin Med J (Engl). 2012 Dec;125(24):4454-9. Chin Med J (Engl). 2012. PMID: 23253719 Clinical Trial.

8

[Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].

Liu JR, Luo SK, Li J, Su C. Liu JR, et al. Among authors: su c. Ai Zheng. 2007 Jun;26(6):652-6. Ai Zheng. 2007. PMID: 17562275 Free article. Chinese.

9

Expression of soluble Flt-1 gene in Pichia pastoris and the effect of the product on multiple-myeloma cells in vitro.

Liu J, Li J, Su C, Huang B, Luo S. Liu J, et al. Among authors: su c. Biotechnol Appl Biochem. 2008 Feb;49(Pt 2):97-104. doi: 10.1042/BA20070053. Biotechnol Appl Biochem. 2008. PMID: 17614789

10

Soluble Fms-like tyrosine kinase-1 expression inhibits the growth of multiple myeloma in nude mice.

Liu J, Li J, Su C, Huang B, Luo S. Liu J, et al. Among authors: su c. Acta Biochim Biophys Sin (Shanghai). 2007 Jul;39(7):499-506. doi: 10.1111/j.1745-7270.2007.00310.x. Acta Biochim Biophys Sin (Shanghai). 2007. PMID: 17622469 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,698 results

Search Page

Filters